Vaxcyte, Inc. (PCVX) Misses Q4 EPS by $4.13
Get Alerts PCVX Hot Sheet
Join SI Premium – FREE
Vaxcyte, Inc. (NASDAQ: PCVX) reported Q4 EPS of ($5.63), $4.13 worse than the analyst estimate of ($1.50).
For earnings history and earnings-related data on Vaxcyte, Inc. (PCVX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA maintains underperform ratings on six BDC stocks
- Boeing names Ryan Shedd as new SVP and controller
- Nuvectis Pharma (NVCT) files $200M mixed shelf
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share